Effect of Mycobacterium tuberculosis on HIV Replication: Role of Immune Activation

Journal of Immunology

Volumn 157, Issue 3, 1996, Pages 1271-1278

  Goletti, Delia ^a,d,e   Weissman, Drew ^a   Jackson, Robert W ^a   Graham, Neil M H ^b   Vlahov, David ^b   Klein, Robert S ^c   Munsiff, Sonal S ^c   Ortona, Luigi ^d   Cauda, Roberto ^d   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d CATHOLIC UNIVERSITY   (Italy)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL DEATH; CYTOLOGY; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LYMPHOCYTE; MYCOBACTERIUM TUBERCULOSIS; PHYSIOLOGY; TUBERCULOSIS; VIROLOGY; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CELL DEATH; HIV-1; HUMANS; LYMPHOCYTES; MYCOBACTERIUM TUBERCULOSIS; TUBERCULIN; TUBERCULOSIS; VIRUS REPLICATION;

EID: 0030209725     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Raviglione, M. C., D. E. Snider, Jr., and A. Kochi. 1995. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic JAMA 273:220.
2. Dolin, P. J., M. C. Raviglione, and A. Kochi. 1994. Global tuberculosis incidence and mortality during 1990-2000. Bull. W. H. O. 72:213.
3. Raviglione, M. C., J. P. Narain, and A. Kochi. 1992. HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment. Bull. W. H. O. 70:515.
4. Centers for Disease Control. Tuberculosis morbidity - United States, 1992. Morb. Mortal. Wkly. Rep. 42:696.
5. Selwyn, P. A., P. Alcabes, D. Hartel, D. Buono, E. E. Schoenbaum. R. S. Klein, K. Davenny, and G. H. Friedland. 1992. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N. Engl. J. Med. 327:1697.
6. Collins, F. M. 1992. Mycobacteria as cofactor in AIDS. Res. Microbiol. 143:369.
7. Barnes, P. F., A. B. Bloch, P. T. Davidson, D. E. Snider, Jr. 1991. Tuberculosis in patients with human immunodeficiency virus infection. N. Engl. J. Med. 324:1644.
8. Hopewell, P. C. 1992. Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin. Infect. Dis. 15:540.
9. Ellner, J. J. 1995. Multidrug-resistant tuberculosis. Adv. Intern. Med. 40:155.
10. Jones, B. E., S. M. Young, D. Antoniskis, P. T. Davidson, F. Kramer, and P. F. Barnes. 1993. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am. Rev. Respir. Dis. 48:1292.
11. Bevilacqua, N., G. Marasca, A. Moscati, M. Fantoni, F. Ricci, and L. Ortona. 1993. Tuberculosis and HIV infection. Lancet 342:677.
12. Graham, N. M. H., N. Galai, K. E. Nelson, J. Astemborski, M. B. Bonds, R. T. Rizzo, L. Sheeley, L. Solomon, and D Vlahov. 1996. Impact of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Arch. Intern. Med. 156:889.
13. Brudney, K., and J. Dobkin. 1991. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am. Rev. Respir. Dis. 144:745.
14. Daley, C. L., P. Small, G. F. Schecter, G. K. Schoolnik, R. A. McAdam, W. R. Jacobs, and P. C. Hopewell. 1992. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. N. Engl. J. Med. 326:231.
15. Di Pierri, G., M. C. Danzi, G. De Checchi, S. Pizzighella, M. Solbiati, M. Cruciani, R. Luzzati, M. Malena, R. Mazzi, E. Concia, and D. Bassetti. 1989. Nosocomial epidemic of active tuberculosis among HIV infected patients. Lancet 2:1502.
16. Villarino, M. E., S. W. Dooley, L. J. Geiter, K. G. Castro, and D. E. Snider, Jr. 1992. Management of persons exposed to multidrug-resistant tuberculosis. Morb. Mortal. Wkly. Rep. 41 (RR-11):61.
17. Whalen, C., C. R. Horsburgh, D. Hom, C. Lahart, M. Simberkoff, and J. Ellner. 1995. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am. J. Respir. Crit. Care Med. 151:129.
18. Pape, J. W., S. S. Jean, J. L. Ho, A. Hafner, and D. W. Johnson, Jr. 1993. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 342:268.
19. Shattock, R. J., J. S. Friedland, and G. E. Griffin. 1993. Modulation of HIV transcription in and release from monocytic cells following phagocytosis of Mycobacterium tuberculosis. Res. Virol. 144:7.
20. Lederman, M. M., D. Georges, D. J. Kusner, P. Mudido, C. Z. Giam, and Z. Toossi. 1994. Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus. J. AIDS 7:727.
21. Zhang, Y., K. Nakata, M. Weiden, and W. N. Rom. 1995. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. J. Clin. Invest. 95:2324.
22. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123.
23. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117.
24. Cheynier, R., S. Henrichwark, F. Hadida, E. Pelletier, E. Oksenhendler, B. Autran, and S. Wain-Hobson. 1994. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell 78:373.
25. O'Brien, W. A., K. Grovit-Ferbas, A. Namazi, S. Ovcak-Derzic, H.-J. Wang, J. Park, C. Yeramian, S.-H. Mao, and J. A. Zack. 1995. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 86:1082.
26. Staprans, S. I., B. L. Hamilton, S. E. Follansbee, T. Elbeik, P. Barbosa, R. M. Grant, and M. B. Feinberg. 1995. Activation of virus replication after vaccination of HIV-1-infected individuals. J. Exp. Med. 82:1727.
27. Stanley, S. K., M. A. Ostrowski, J. S. Justement, K. Gantt, S. Hedayati, M. Mannix, K. Roche, D. J. Schwanzentruber, C. H. Fox, and A. S. Fauci. Effect of immunization with a common recall antigen on plasma viremia and in vitro virus isolation in HIV-1 infected individuals. N. Engl J. Med. 19:1222.
28. Goletti, D., A. L. Kinter, P. Biswas, S. M. Bende, G. Poli, and A. S. Fauci. 1995. Effect of cellular differentiation on cytokine-induced expression of human immunodeficiency virus in chronically infected promonocytic cells: dissociation of cellular differentiation and virul expression. J. Virol. 69:2540.
29. Dewar, R. L., H. C. Highbarger, M. D. Sarmiento, J. A. Todd, M. B. Vasudevachari, R. T. Davey, Jr., J. A. Kovacs, N. P. Salzman, H. C. Lane, and M. S. Urdea. 1994. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J. Infect Dis. 170:1172.
30. Cohen, O. J., G. Pantaleo, M. Holodniy, S. Schnittman, M. Niu, C. Graziosi. G. N. Pavlakis, J. Lalezari, J. A. Bartlett, R. T. Steigbigel, and A. S. Fauci. 1995. Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue. Proc. Natl. Acad. Sci. USA 92:6017.
31. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355.
32. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359.
33. + T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc. Natl. Acad. Sci. USA 92:2308.
34. + T cells and this effect overrides its ability to stimulate virus expression. Proc. Natl. Acad. Sci. USA 92:10985.
35. Zack, J. A., A. M. Haislip, P. Krogstad, and I. S. Chen. 1992. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66:1717.
36. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals labile, latent viral structure. Cell 61:213.
37. Bukrinsky, M. I., T. L. Stanwick, M. P. Dempsey, and M. Stevenson. 1991. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254:423.
38. + T cells in acute HIV infection in vitro. J. Immunol. 150:5202.
39. Fultz, P. N., J.-C. Gluckman, E. Muchmore, and M. Girard. 1992. Transient increases in numbers of infectious cells in an HIV-infected chimpanzee following immune stimulation. AIDS Res. Hum. Retroviruses 8:313.
40. smmPBj14: correlation between in vitro and in vivo events. J. Virol. 68:5538.
41. Ho, D. 1992. HIV-1 viraemia and influenza. Lancet 33:1549.
42. Fauci, A. S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262:1011.
43. Snider, D. E. 1989. Research towards global control and prevention of tuberculosis: introduction. Rev. Infect. Dis. 11 (Suppl):S336.
44. Toossi, Z., J. G. Sierra-Madero, R. A. Blinkhorn, M. A. Mettler, and E. A. Rich. 1993. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J. Exp. Med. 177:1511.
45. Heng, M. C. Y., S. Y. Heng, and S. G. Allen. 1994. Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1. Lancet 343:255.
46. Israel-Biet, D., J. Cadranel, and P. Even. 1993. Human immunodeficiency virus production by alveolar lymphocytes is increased during Pneumocystis carinii pneumonia. Am. Rev. Respir. Dis. 148:1308.
47. Denis, M., and E. Ghadirian. 1994. Mycobacterium avium infection in HIV-1-infected subjects increases monokine secretion and is associated with enhanced viral load and diminished immune response to viral antigens. Clin. Exp. Immunol. 97:76.
48. Claydon, E. J., J. Bennett, D. Gor, and S. M. Forster. 1991. Transient elevation of serum HIV antigen levels associated with intercurrent infection. AIDS 5:113.
49. Gilks, C. F. 1993. The clinical challenge of the HIV epidemic in the developing world. Lancet 342:1037.
50. N'Galy, B., R. W. Ryder, K. Bila, K. Mwandagalirwa, R. L. Colebunders, H. Francis, J. M. Mann, and T. C. Quinn. 1988. Human immunodeficiency virus infection among employees in an African hospital. N. Engl. J. Med. 319:1123.
51. Quinn, T. C. 1995. The epidemiology of the acquired immunodeficiency syndrome in the 1990s. Emerg. Med. Clin. North Am. 13:1.
52. Medley, G. F., R. M. Anderson, D. R. Cox, and I. L. Billard. 1987. Incubation period of AIDS in patients infected via blood transfusion. Nature 328:719.
53. Bentwich, Z., A. Kalinkovich, and Z. Weisman. 1995. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol. Today 16:187.
54. De Cock, K. M., B. Soro, I. M. Coulibaly, and S. B. Lucas. 1992. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 268:1581.
55. Mukadi, Y., J. H. Perriens, M. E. St. Louis, C. Brown, J. Prignot, J. C. Willame, F. Pouthier, M. Kaboto, R. W. Ryder, F. Portaels, and P. Piot. 1993. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet 342:143.